Transmembrane protein 25 abrogates monomeric EGFR‐driven STAT3 activation in triple‐negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transmembrane protein 25 abrogates monomeric EGFR‐driven STAT3 activation in triple‐negative breast cancer

Published:2024-03-26 Issue:4 Volume:5 Page:
ISSN:2688-2663
Container-title:MedComm
language:it
Short-container-title:MedComm

Author:

Mohan Chakrabhavi Dhananjaya¹,Rangappa Kanchugarakoppal S.²,Sethi Gautam³

Affiliation:

1. FEST Division CSIR‐Indian Institute of Toxicology Research Lucknow Uttar Pradesh India

2. Institution of Excellence, Vijnana Bhavan University of Mysore Mysore Karnataka India

3. Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.492

Reference4 articles.

1. TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression

2. The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas

3. TMEM25, REPS2 and Meis 1: Favourable Prognostic and Predictive Biomarkers for Breast Cancer

4. TMEM25Is a Candidate Biomarker Methylated and Down-Regulated in Colorectal Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP